LevitasBio strengthens executive leadership team, tapping seasoned commercial and finance veterans from biotech industry

MENLO PARK, CA LevitasBio, biotech leader in label-free sample enrichment for cellular analysis, today announced the expansion of its leadership team with the appointment of two senior leaders from the biotech industry to lead commercial strategy and finance.  Paul Steinberg, a veteran commercial and strategic leader in life sciences tools, has been appointed Chief Commercial […]

LevitasBio secures $18 million in Series B funding led by Thalys Medical

MENLO PARK, CA LevitasBio, a life science tools leader in label-free sample enrichment for cellular analysis, today announced the closing of its $18 million Series B financing round, led by Thalys Medical and joined by Series A lead investor Decheng Capital.   The company is the manufacturer of the LeviCell – the world’s first label-free […]

Levitation simplified: Levitas featured by Mission Unstoppable

Our very own Field Applications Scientist, Danielle Twum, PhD, was featured by CBS’s Mission Unstoppable hosted by Miranda Cosgrove. The show aims to “celebrate women who have become superstars in STEM-related careers – science, technology, engineering, and math.” Given it’s a younger audience, the program does a great job of breaking down the science behind […]

Stanford Spinout LevitasBio to Launch Magnetic Levitation Cell Separation Platform

Excerpt from the article published by Genomeweb here. NEW YORK – LevitasBio, a Stanford University spinout, is preparing the launch of a technology that sounds nearly imaginary: magnetic levitation-based cell separation.”Unlike anything else out there, when it comes to separating particles, we don’t attach or bind anything to the cells,” said CEO Martin Pieprzyk. “No […]